StockData
Kailera Therapeutics, Inc. logo

Kailera Therapeutics, Inc. (KLRA) KPIs and segments

KLRANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026
$12.20−0.37 (-2.94%)

Close on Nov 17, 2026Market cap $1.58BP/E –Yield –

KPIs & segments

Operating metrics and segments that drive Kailera Therapeutics's business

Coming soon

This tab will track the numbers specific to Kailera Therapeutics's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?